Asthma clinical trials in Colorado
18 studies for Asthma are looking for participants at sites in Colorado.
Cities in Colorado
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Colorado Springs
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT07301255A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Asthma & Allergy Associates - Colorado Springs, Colorado Springs
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07219173Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Research Site, Aurora
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Sep 22, 2026 · NCT07444567A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Colorado ENT & Allergy, Colorado Springs
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 15, Colorado Springs
RecruitingPhase 3
Ages 12 to 80 · All sexes · Updated Sep 21, 2026 · NCT07276724PULmonary Stimulation for Asthma Relief
- National Jewish Health, Denver
Recruiting
Ages 18 to 75 · All sexes · Updated Sep 16, 2026 · NCT07709754A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Colorado Springs
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 9, 2026 · NCT05757102A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12142, Lakewood
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 31, 2026 · NCT06664619A Study of Depemokimab in Participants of 6 to 11 Years of Age
- GSK Investigational Site, Colorado Springs
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Aug 26, 2026 · NCT07671001Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Children's Hospital Colorado: Allergy Program, Aurora
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 21, 2026 · NCT05272241A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, Aurora
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 17, 2026 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Denver
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Aug 13, 2026 · NCT06307665Protocol CAUSE-03 / CHEETAH
- Children's Hospital Colorado: Allergy Program, Aurora
RecruitingObservational studyHealthy volunteers welcome
Ages 6 to 17 · All sexes · Updated Jul 1, 2026 · NCT06136091Individualizing Treatment for Asthma in Primary Care (Full Study)
- DARTNet Institute, Aurora
- University Colorado-Denver, Aurora
RecruitingPhase 4
Ages 13 to 75 · All sexes · Updated Oct 29, 2025 · NCT07052942Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
- University of Colorado Anschutz Medical Campus, Aurora
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jun 10, 2025 · NCT03762395Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
- National Jewish Health, Denver
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Apr 6, 2023 · NCT05259904Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
- University of Colorado, Aurora
Recruiting
Ages 18 to 65 · All sexes · Updated Feb 2, 2023 · NCT03215836Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
- National Jewish Health, Denver
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2017 · NCT02947945From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.